Erector spinae plane block for pain relief after ureterorenoscopy surgery
Efficacy of Erector Spinae Plane Block in Flexible Ureterorenoscopy (URS) Surgery: a Randomized Controlled Trial
This study is testing if a special pain relief technique called the erector spinae plane block can help people feel less pain after ureterorenoscopy surgery compared to regular pain management.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Namik Kemal University Academic / other |
| Locations | 1 site (Tekirdağ) |
| Trial ID | NCT06826833 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of the erector spinae plane (ESP) block in providing postoperative pain relief for patients undergoing flexible ureterorenoscopy (URS) surgery. Participants will be randomly assigned to either receive the ESP block with bupivacaine or standard pain management without the block. The study will assess pain levels, opioid consumption, the need for additional pain treatment, and the incidence of postoperative nausea and vomiting (PONV) in the first 24 hours after surgery. The ESP block will be administered under ultrasound guidance to ensure accurate placement of the anesthetic.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 undergoing elective flexible ureterorenoscopy with an ASA classification of I-II.
Not a fit: Patients with a BMI over 35, allergies to local anesthetics, or those requiring emergency surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and reduce opioid use after URS surgery.
How similar studies have performed: Other studies have shown promising results with the use of ESP blocks for postoperative analgesia, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients undergoing elective flexible ureterorenoscopy (URS). Age: 18-65 years. ASA I-II. Willing to participate and provide written informed consent. Exclusion Criteria: BMI \>35 kg/m². Allergy to local anesthetics. Coagulation disorders or use of anticoagulants. Patients requiring emergency surgery. Patients with infection at the ESP block site.
Where this trial is running
Tekirdağ
- Tekirdağ Namık Kemal University Research Hospital — Tekirdağ, Turkey (Recruiting)
Study contacts
- Principal investigator: Ayhan Şahin, Assoc. Prof. — Namik Kemal University
- Study coordinator: Ayhan Şahin, Assoc. Prof.
- Email: drayhan.sahin@hotmail.com
- Phone: +905324730503
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.